Atlas Trials

Pharmacokinetics and Safety of SHR0302 in Patients With Hepatic Impairment

Clinical trial NCT04293029 · COMPLETED

Trial details

NCT number
NCT04293029
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic Impairment
Start date
2020-05-20
Primary completion
2020-12-27
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.